INSL5 may be a unique marker of colorectal endocrine cells and neuroendocrine tumors.

作者: Hirosato Mashima , Hideki Ohno , Yumi Yamada , Toshitaka Sakai , Hirohide Ohnishi

DOI: 10.1016/J.BBRC.2013.02.042

关键词:

摘要: Insulin-like peptide 5 (INSL5) is a member of the insulin superfamily, and potent agonist for RXFP4. We have shown that INSL5 expressed in enteroendocrine cells (EECs) along colorectum with gradient increase toward rectum. RXFP4 ubiquitously digestive tract. INSL5-positive EECs little immunoreactivity to chromogranin A (CgA) might be unique marker colorectal EECs. CgA-positive were distributed normally null mice, suggesting not required development Exogenous did affect proliferation human colon cancer cell lines, chemically-induced colitis mice show any significant changes inflammation or mucosal healing compared wild-type mice. In contrast, all rectal neuroendocrine tumors examined co-expressed may EECs, INSL5–RXFP4 signaling play role an autocrine/paracrine fashion epithelium tumors.

参考文章(33)
Linda K. Woods, Robert T. Morgan, Laurie A. Quinn, George E. Moore, Cell Lines from Human Colon Carcinoma with Unusual Cell Products, Double Minutes, and Homogeneously Staining Regions Cancer Research. ,vol. 39, pp. 4914- 4924 ,(1979)
Kazuko Shichijo, Mutsumi Matuu, Yuji Ikeda, Shinji Naito, Masahiro Ito, Ichiro Sekine, Clinicopathologic study of dextran sulfate sodium experimental murine colitis Laboratory Investigation. ,vol. 69, pp. 238- 249 ,(1998) , 10.1016/S0021-5198(19)41298-5
B. Drewinko, M. J. Ahearn, L. Y. Yang, J. M. Trujillo, M. M. Romsdahl, Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Research. ,vol. 36, pp. 467- 475 ,(1976)
Isao Okayasu, Shigeru Hatakeyama, Masahiro Yamada, Toshifumi Ohkusa, Yoshio Inagaki, Rintaro Nakaya, A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology. ,vol. 98, pp. 694- 702 ,(1990) , 10.1016/0016-5085(90)90290-H
A.G. Fahrenkamp, C. Wibbeke, W. B�cker, K.W. Schmid, G. Winde, D. �fner, R. Fischer-Colbrie, Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract Virchows Archiv. ,vol. 426, pp. 361- 367 ,(1995) , 10.1007/BF00191345
G. E. Callander, R. A. D. Bathgate, Relaxin family peptide systems and the central nervous system Cellular and Molecular Life Sciences. ,vol. 67, pp. 2327- 2341 ,(2010) , 10.1007/S00018-010-0304-Z
Changlu Liu, Jingcai Chen, Steven Sutton, Barbara Roland, Chester Kuei, Niven Farmer, Rannar Sillard, Timothy W. Lovenberg, Identification of relaxin-3/INSL7 as a ligand for GPCR142. Journal of Biological Chemistry. ,vol. 278, pp. 50765- 50770 ,(2003) , 10.1074/JBC.M308996200
Galen Cortina, Chandra N. Smart, Douglas G. Farmer, Sunita Bhuta, William R. Treem, Ivor D. Hill, Martín G. Martín, Enteroendocrine cell dysgenesis and malabsorption, a histopathologic and immunohistochemical characterization Human Pathology. ,vol. 38, pp. 570- 580 ,(2007) , 10.1016/J.HUMPATH.2006.10.014
K. Funa, B. Eriksson, E. Wilander, K. �berg, In situ hybridization study of chromogranin A and B mRNA in carcinoid tumors. Histochemistry and Cell Biology. ,vol. 95, pp. 555- 559 ,(1991) , 10.1007/BF00266741
Sabine Hombach-Klonisch, Joanna Bialek, Yvonne Radestock, Anne Truong, Alexander I. Agoulnik, Barbara Fiebig, Cornelia Willing, Ekkehard Weber, Cuong Hoang-Vu, Thomas Klonisch, INSL3 has tumor‐promoting activity in thyroid cancer International Journal of Cancer. ,vol. 127, pp. 521- 531 ,(2010) , 10.1002/IJC.25068